The SMART trial raised questions about balloon-expandable valves in small aortic annuli; these new data offer some answers.

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

Written to offer advice where formal guidelines fall short, the document urges a balance between bleeding and ischemic risk.

The study was stopped early to allow all patients with advanced PAH the option for treatment with the activin signaling ...

A multistate model that enables real-time risk recalculations may help improve risk stratification for prediction of ...

Investigators saw more deaths in patients with severe TR after repeat mitral valve procedures; what to do about it is unclear ...

People who talk in their sleep may be at greater risk of stroke, according to a study of 8,001 Chinese adults. The risk was ...

LONDON, ENGLAND—Clinical and echocardiographic outcomes with the latest-generation balloon-expandable Sapien 3 Ultra Resilia ...

The preliminary data open the door to an alternative approach to invasive monitoring in heart failure patients.

Acoramidis becomes the second drug ever approved for this condition, based on the results of the ATTRibute-CM trial.

Much remains to learn about this anatomical finding, seen in about one-third of adults, and how it may affect stroke risk.

These data should help reassure those concerned with the risks of educating physicians through live cases at medical meetings ...